Dear Editor,
The importance of folic acid (FA) in the prevention of neural tube defects (NTD) involving failure of neural tube (NT) closure in the developing embryo is well established. Various forms of NTD, especially spina bifida and anencephaly, can be prevented by supplementing the diet with FA in the periconceptional period.1,2 How FA acts to prevent NTD is still unknown. Nitric oxide (NO) had been shown to be able to induce NTD in 10.5-day rat embryos,3 and biochemical studies showed that NO inhibits methionine synthase (MS), by interfering with the transfer of the methyl group from the methyl donor 5-methyl-tetrahydrofolate (5mTHF) to homocysteine.4 We have shown that endogenously produced NO in the neuroepithelium, at the time of NT closure, plays a role in cell cycle progression5 and the regulation of cell numbers in the developing NT.6 We also found that high NO levels increase the demand for folates.6 Here, we describe experiments that examine the direct effect of FA and NO produced by the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) on the process of NT closure in the chick embryo ex ovo. The data here demonstrate that exposure to NO produced by SNAP results in an open NT by inhibition of the MS reaction, thus interfering with the flow of one carbon unit through the folate pathway, possibly by vitamin B12 poisoning. These effects of NO can be effectively alleviated by FA or vitamin B12. Thus, the findings described here may explain why FA supplementation during pregnancy prevents NT closure defects. The experimental system used here is focused on a defined 6 h window between the eight and 12 somite stage in chick embryo development. This is the time when NT closure takes place by a process that involves programmed cell death.7 Eight somite-stage embryos were explanted as previously described,8 and cultured for 6 h individually in DMEM conditioned agarose dishes, in the presence of the NO donor SNAP (2 mM) with or without 50 μg/ml FA. The effects of these treatments on normal NT closure in whole mount and serial NT transverse sections of 12 somite stage embryos are shown in Figure 1a. The NO levels produced by SNAP treatment in our experimental system clearly interfere with NT closure. While FA alone had no effect on NT closure, its addition to the SNAP-treated embryos alleviated the SNAP effect by a complete restoration of NT closure.
To further verify that NO is indeed the factor responsible for the NTD, experiments were performed using 4 μg/ml hemoglobin to quench NO.9 This hemoglobin treatment in fact counteracted the SNAP effect on NT closure, resulting in normal NT closure rates (22±3% open NT transverse sections, P<0.001 significance by two-way ANOVA). The observation that SNAP produced NO inhibits NT closure in the chick embryo and that this inhibition is counteracted by FA raised the possibility that NO interferes with one carbon unit metabolism. This conclusion is corroborated by a recent report suggesting that NO inhibits the MS reaction, thereby blocking the flow of one carbon units through the folate pathway.4 Our results and this report prompted us to examine the possibility that NO induction of NTD is caused by inhibition of the MS reaction. To this end, eight somite stage embryos were treated with 2 mM SNAP in the presence or absence of FA. For the last 4 h of incubation, 5-[14C]m-THF was added to the embryo culture. At the end of the experiment (12 somite stage), NT closure was assessed in whole mount preparations and the embryos were processed for assaying the MS reaction by measuring the incorporation of labelled methyl groups into TCA-precipitable material. The correlation between MS activity and NT closure is demonstrated in Figure 1b. High MS activity was detected in 12 somite embryos with closed NT morphology. In this category were most of the untreated embryos and those treated with a combination of SNAP and FA. Decreased MS activity was detected in embryos treated with SNAP alone, in which open NT morphology was observed. These results suggest that normal NT closure requires normal MS activity. One carbon unit flow associated with MS activity can be used therefore as a biochemical marker of normal NT closure.
To further characterize the inhibitory effects of NO on the MS reaction and its dependence on FA availability, we assayed MS activity in dose response experiments with FA and SNAP in pooled embryo cultures. A clear concentration-dependent effect of SNAP on MS activity was observed, and that FA at a concentration of 50 μg/ml completely restored normal MS activity (Figure 1c). Since NO is known to interact with cobalamin (vitamin B12),4 a known cofactor in the methyl transfer reaction, we argued that the effect of NO on the methyl group transfer reaction may be a result of sequestration of this cofactor by NO. To test this possibility, we added 50 μg/ml of vitamin B12 to the MS assay system, and found that, at this concentration, vitamin B12 significantly restores MS activity in embryos exposed to 2 mM SNAP (Figure 1c). It is therefore tempting to speculate that the molecular mechanism by which NO inhibits the carbon flow through the folate pathway involves cobalamin poisoning by NO. This interpretation of the results led us to the conclusion that the inhibition of the one carbon flow by NO in cultured embryos may be at the cofactor level of the MS reaction.
The interrelations between NO levels, FA availability and NT closure defect suggested in this letter are illustrated in Figure 1d. Adequate one carbon unit flow, which is mediated by MS and FA dependent, is required for normal NT closure between the eight and 12 somite-embryo stage. Although we cannot precisely specify the NO levels that are required for the normal process of NT closure, it is clear that high NO levels that are capable of poisoning B12, an essential cofactor of the MS enzyme, interfere with the NT closure process. FA is clearly required to prevent the deleterious effect of high NO on NT closure. The observations described here shed light on the molecular mechanisms that underlie FA deficiency and human congenital NT defects, and could give at least one molecular explanation for the necessity of FA dietary supplementation during pregnancy, and how this can prevent these devastating human congenital defects.
References
Czeizel AE and Dudas I (1992) N. Engl. J. Med. 327: 1832–1835
Wald N (1991) Eur. J. Pediatr. Surg. 1 (Suppl 1): 41–42
Lee QP and Juchau MR (1994) Teratology 49: 452–464
Danishpajooh IO et al. (2001) J. Biol. Chem. 276: 27296–27303
Traister A et al. (2002) Dev. Dyn. 225: 271–276
Plachta N, Traister A and Weil M (2003) Exp. Cell Res. 288: 354–362
Weil M, Jacobson MD and Raff MC (1997) Curr. Biol. 7: 281–284
Chapman SC et al. (2001) Improved method for chick whole-embryo culture using a filter paper carrier. Dev. Dyn. 220: 284–289
Kharitonov V et al. (1996) In Methods in Nitric Oxide Research Feelisch M and Stamler J, eds (London: Wiley)
Acknowledgements
We thank Tal Beckerman for her technical help. This research was supported by the Israel Science Foundation Grant 6/10-17.2 and by The Adams Super Center for Brain Studies award, Tel Aviv University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weil, M., Abeles, R., Nachmany, A. et al. Folic acid rescues nitric oxide-induced neural tube closure defects. Cell Death Differ 11, 361–363 (2004). https://doi.org/10.1038/sj.cdd.4401371
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401371
This article is cited by
-
The 894G>T variant in the endothelial nitric oxide synthase gene and spina bifida risk
Journal of Human Genetics (2007)